P2RY12 and Alzheimer disease: Among the most promising novel tracers are those that target purinergic receptors including P2X7, selective towards the M1 phenotype and overexpressed in AD brain, and P2Y12, selective towards the M2 phenotype and with reduced expression around Aβ plaques in AD brain [42].